- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02723097
A Pilot Test of the Relaxation Response Resiliency Program (3RP) in Spanish Speaking World Trade Center Survivors With Post Traumatic Stress Disorder (PTSD)
October 16, 2017 updated by: NYU Langone Health
The objective of this protocol is to test the feasibility and acceptability of the Relaxation Response Resiliency Program (3RP), a psychotherapy treatment providing a variety of mind body skills and interventions to decrease medical and mental health symptoms and build resilience, in Spanish-speaking World Trade Center (WTC) survivors, and to examine its clinical effectiveness to reduce Post Traumatic Stress Disorder (PTSD), depression, anxiety, and lower respiratory symptoms (LRS) and improve psychosocial functioning.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10016
- New York University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- score > or = 44 on the PTSD Checklist PCL, considered the broad definition of PTSD syndrome71
- report at least one LRS symptoms (i.e., shortness of breath, wheezing, dyspnea or cough).
- Spanish Speaking
Exclusion Criteria:
- regular practice of eliciting relaxation response (i.e., meditation, yoga) in the past 6 months,
- serious unmanaged mental illness including bipolar disorder, psychosis, and active substance misuse disorders;
- inability to participate in consecutive sessions over 3-month period.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Relaxation Response Resiliency Program (3RP)
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Structured Clinical Interview (SCID-NP) for Diagnostic and Statistical Manual DSM-IV
Time Frame: 1 Month
|
State-of-the-art instrument for obtaining psychiatric diagnoses.
|
1 Month
|
|
Symptom Severity using PTSD Checklist
Time Frame: 1 Month
|
Symptoms will be assessed with the PTSD Checklist (PCL), a 17-item self-report measure of current (past month) PTSD symptoms based on the DSM-IV criteria.
It is a widely-used and validated measure of PTSD symptom severity.
|
1 Month
|
|
Assessment of Anxiety Symptoms using Generalized Anxiety Disorder Scale (GAD-7)
Time Frame: 1 Month
|
1 Month
|
|
|
Measure of Functional Impairment using the Range of Impaired Functioning Tool (RIFT)
Time Frame: 1 Month
|
widely-used instrument that taps the domains of work, household duties, interpersonal relationships, recreation, and subjective satisfaction with life.
Each domain is rated on a five-point scale from very good to very poor.
The total score is the sum of the different domains.
|
1 Month
|
|
Assessment of Mindful attention using Mindful Attention Awareness Scale (MAAS)
Time Frame: 1 Month
|
The MAAS is a 15-item questionnaire on which respondents indicate, on a 6 point Likert-type scale (1 = almost always to 6 = almost never), their level of awareness and attention to present events and experiences.
|
1 Month
|
|
Health Promoting Behaviors will be assessed with the Health Promoting Lifestyles Profile-II (HPLP-II)
Time Frame: 1 Month
|
he HPLP-II is a 52 item self-report inventory of health behaviors and has been used in previous mind-body treatment studies
|
1 Month
|
|
Measure of treatment expectancy using the Treatment Credibility/Expectancy Questionnaire.
Time Frame: 1 Month
|
The 6-item Treatment Credibility/Expectancy Questionnaire (CEQ)84 will be used to examine treatment expectancy related to the 3RP.
|
1 Month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Lucia Ferri, MD, New York University Medical School
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2016
Primary Completion (Actual)
October 11, 2017
Study Completion (Actual)
October 11, 2017
Study Registration Dates
First Submitted
March 24, 2016
First Submitted That Met QC Criteria
March 24, 2016
First Posted (Estimate)
March 30, 2016
Study Record Updates
Last Update Posted (Actual)
October 18, 2017
Last Update Submitted That Met QC Criteria
October 16, 2017
Last Verified
October 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15-00721
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post Traumatic Stress Disorder (PTSD)
-
Acacia ClinicsElectroCore INC; Vagus Nerve SocietyRecruitingPTSD | Post Traumatic Stress Disorder | Post Traumatic Stress Disorders | Post-traumatic Stress Disorder (PTSD) | Post Traumatic Stress Disorder PTSD | PTSD - Post Traumatic Stress Disorder | Post-Traumatic Stress Disorder, PTSDUnited States
-
University of LuxembourgQuresta, Inc.; National Psychological Association of Ukraine; Veteran Mental...RecruitingPost Traumatic Stress Disorder | Post Traumatic Stress Disorder PTSD | Post-Traumatic Stress Disorder, PTSDUkraine
-
COMPASS PathwaysNot yet recruitingPTSD | PTSD, Post Traumatic Stress Disorder | PTSD Symptoms | PTSD - Post Traumatic Stress Disorder
-
Region ÖstergötlandCompletedPTSD | PTSD (Childbirth-Related) | Post Traumatic Stress | PTSD - Post Traumatic Stress Disorder | Childbirth-related PTSDSweden
-
University of Texas Southwestern Medical CenterTexas Child Mental Healthcare Consortium (TCMHCC)Active, not recruitingPost-Traumatic Stress Disorder in Adolescence | PTSD - Post Traumatic Stress Disorder | PTSD and Trauma-related Symptoms | Pregnancy and PTSDUnited States
-
Dokuz Eylul UniversityCompletedPost-Traumatic Stress Disorder (PTSD)Turkey
-
The University of Texas at ArlingtonUniversity of Texas at AustinTerminatedPost-traumatic Stress Disorder (PTSD)United States
-
VA Office of Research and DevelopmentRecruitingPost-Traumatic Stress Disorder (PTSD)United States
-
Nepalese Psychological AssociationUnknownPost-traumatic Stress Disorder (PTSD)Nepal
-
NYU Langone HealthCompleted
Clinical Trials on 3 RP
-
Ewha Womans UniversityCompletedOsteoarthritisKorea, Republic of
-
European Organisation for Research and Treatment...RecruitingAll Tumor TypesFrance, Spain, United Kingdom, Belgium, Switzerland, Netherlands, Germany, Austria, Cyprus, Czechia, Estonia, Greece, Italy, Lithuania, Poland, Portugal, Slovenia, Serbia, Croatia, Romania
-
Haitao Niu, MDNot yet recruitingProstate Cancer Patients Undergoing Radical ProstatectomyChina
-
DePuy InternationalTerminated
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH)CompletedObsessive-Compulsive DisorderUnited States
-
Swiss Group for Clinical Cancer ResearchTerminated
-
Recurv Pharma IncNot yet recruitingCancer | Colorectal Cancer | Pancreatic Cancer | Oncology | Advanced Malignancies
-
Rocket Pharmaceuticals Inc.Enrolling by invitationFanconi AnemiaSpain, United States, United Kingdom
-
Rocket Pharmaceuticals Inc.Active, not recruitingDanon DiseaseUnited States
-
Rocket Pharmaceuticals Inc.UnknownFanconi Anemia Complementation Group AUnited States